She considers herself 80 percent recovered from the operation. You feel your whole world crashing around you. The idea is to lower the overall cost of research so the treatments can be commercially viable and available to those desperately needing them. Reducing clinical trial costs can be the difference between bringing new treatments online and medical companies closing their labs, Tunstall says. She knows first hand how difficult it can be to find patients for clinical trials.
Biotech companies live funding to funding.
If you can accelerate your time, you might cause more companies to survive. This is one of those situations that are rare in business where I don't see anybody who doesn't benefit. Countless patients never hook up with available trials. For instance, a mere 3 percent of women with breast cancer who could be involved with clinical trials actually participate in them, Tunstall says. It's not that clinical trial information isn't out there somewhere, Messemer observes.